Critical Care

@Crit_Care · London, UK · joined 24 Jul 2013

Critical Care is an international open access journal that publishes articles in all areas of intensive care and emergency medicine.

56 693Followers

689Following

8 133Posts total

24.2KViews on collected posts

Últimas publicaciones

Critical Care@Crit_Care16 Sep

@Crit_Care Several multi-center RCTs have already tried to answer this question. Do you really think that an overlap-weighted retrospective cohort study will meaningfully add to existing knowledge? https://t.co/vwJ0RKKWiP

GIF

766 views · 14 likes · 1 reposts · 2 replies Open on X →

Critical Care@Crit_Care16 Sep

🥼New in #SepsisAndSevereInfection: Overlap-weighted retrospective cohort study of early versus delayed renal replacement therapy in sepsis-associated AKI https://t.co/z4mhtxxJ0F #CritCare #Sepsis #SevereInfection #RRT 11.2K views · 15 likes · 3 reposts · 1 replies Open on X →

Critical Care@Crit_Care14 Sep

🦠New in #CriticalCare: The evolution of biocontainment unit care for high-consequence infectious diseases: progress, lessons learned, and future directions https://t.co/uiK0wJXsvH #CritCare #Biocontainment #InfectiousDisease 2.1K views · 5 likes · 2 reposts · 0 replies Open on X →

Critical Care@Crit_Care11 Sep

🏥New in #CriticalCare: Patient-level reclassification and discordance between SOFA and SOFA-2: a multicenter ICU study https://t.co/vGzhD2eoZ9 #CritCare #SOFA #ICU 2.1K views · 16 likes · 0 reposts · 0 replies Open on X →

Critical Care@Crit_Care9 Sep

💻New in #CriticalCare: The impact of an intensive care telemedicine program on weaning from invasive ventilation: a secondary analysis of the ERIC trial https://t.co/fshZ2edmi7 #CritCare #Telemedicine #Ventilation #ICU 2.1K views · 5 likes · 0 reposts · 0 replies Open on X →

Critical Care@Crit_Care7 Sep

@Crit_Care The host-response heterogeneity angle raises a practical question: can these phenotypes be identified early enough to guide treatment, before pneumonia progresses to sepsis? I’m digging into it with Sci-Quest, a platform for biomedical literature reviews: https://t.co/ 284 views · 0 likes · 0 reposts · 0 replies Open on X →

Critical Care@Crit_Care7 Sep

🤒New in #SepsisAndSevereInfection: Rethinking pneumonia as a pathway to sepsis: host response and clinical heterogeneity https://t.co/HTXv75MItg #CritCare #Sepsis #SevereInfection #Pneumonia 5.6K views · 61 likes · 21 reposts · 2 replies Open on X →

Frente a cuentas del mismo tamaño

7 publicaciones de los últimos 90 días, junto al rango de 10K–100K seguidores. alcance normal para su tamaño, reacción más débil que la mayoría.

Visualizaciones medianas2 100esta cuenta993mediana de 10K–100K

Alcance, %3.70%esta cuenta3.86%mediana de 10K–100K

Interacción, %0.33%esta cuenta1.53%mediana de 10K–100K

Métrica	Esta cuenta	Mediana de 10K–100K	Proporción
Visualizaciones medianas por publicación	2 100	993	2.11×
Alcance (visualizaciones ÷ seguidores)	3.70%	3.86%	0.96×
Tasa de interacción	0.33%	1.53%	0.22×

Otras cuentas de este rango → Comparar con otra cuenta → Cómo se construyen estas referencias →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

5.6K7 Sep

284

2.1K9 Sep

2.1K11 Sep

2.1K14 Sep

11.2K16 Sep

766

Last 7 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

1.51%7 Sep

0.00%

0.23%9 Sep

0.76%11 Sep

0.33%14 Sep

0.18%16 Sep

2.22%

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.53%.

What the audience does

Likes60.1%116 in total

Reposts14.0%27 in total

Replies2.6%5 in total

Quotes0.5%1 in total

Bookmarks22.8%44 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.